Avraham Pharmaceuticals avphar.com

Avraham Pharmaceuticals is a pharmaceutical company developing products for treatment and/or prevention of neurodegenerative disorders. The company's lead product candidate, ladostigil, is in Phase 2 for Alzheimer's disease. Ladostigil is a multifunctional compound that combines proven anti-symptomatic mechanisms of action with neuroprotective mechanisms, and was designed to provide durable, broad symptomatic treatment outcomes and disease-modification.

Avraham Pharmaceuticals is a pharmaceutical company developing products for treatment and/or prevention of neurodegenerative disorders. The company's lead product candidate, ladostigil, is in Phase 2 for Alzheimer's disease. Ladostigil is a multifunc...Show all

Company (Alive / Active)

All investors data 6 Investors

• Clal Biotechnology Industries
• Integra Holdings
• Pontifax
• Prof. Marta Weinstock-Rosin
• Technion Research & Development Foundation

There is no Investors data available for this company. Please select another tab.

There is no Board of Directors data available for this company. Please select another tab.

Board Members

There is no Competitors data available for this company. Please select another tab.

Competitors

See all 0 competitors

Patents